By Fola Akinnibi ( September 6, 2016, 6:00 PM EDT) -- Science and technology giant Danaher Corp. said Tuesday that it would buy California-based molecular diagnostics company Cepheid in a deal valued at about $4 billion, including debt and net cash on hand, marking Danaher's first major move after its July spinoff of certain business units....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.